via What's New: Vaccines, Blood & Biologics RSS Feed http://ift.tt/1kao64z
Thursday, June 5, 2014
June 05, 2014 at 07:06PM Guidance for Industry and FDA Staff: IND Applications for Minimally Manipulated, Unrelated Allogeneic Placental/Umbilical Cord Blood Intended for Hematopoietic and Immunologic Reconstitution in Patients with Disorders Affecting the Hematopoietic System
via What's New: Vaccines, Blood & Biologics RSS Feed http://ift.tt/1kao64z
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment